Scarica l'app Stockscreener
4.76
1.86%
-0.09
Dopo l'orario di chiusura:
4.76
Lexeo Therapeutics Inc Borsa (LXEO) Ultime notizie
Institutional scanner results for Lexeo Therapeutics Inc.M&A Rumor & Growth Oriented Trade Recommendations - Newser
Strategies to average down on Lexeo Therapeutics Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
What high frequency data says about Lexeo Therapeutics Inc.2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Analyzing Lexeo Therapeutics Inc. with multi timeframe charts2025 Earnings Surprises & Community Consensus Trade Alerts - Newser
How sentiment analysis helps forecast Lexeo Therapeutics Inc.Trade Performance Summary & Consistent Income Trade Ideas - Newser
Published on: 2025-08-28 05:54:37 - Newser
Real time alert setup for Lexeo Therapeutics Inc. performanceQuarterly Market Summary & Safe Capital Allocation Plans - Newser
Is Lexeo Therapeutics (NASDAQ:LXEO) In A Good Position To Invest In Growth? - Yahoo Finance
Can trapped investors hope for a rebound in Lexeo Therapeutics Inc.Quarterly Profit Report & Real-Time Volume Analysis - Newser
Price momentum metrics for Lexeo Therapeutics Inc. explainedBreakout Watch & High Accuracy Swing Trade Signals - Newser
How to recover losses in Lexeo Therapeutics Inc. stock2025 Macro Impact & Low Drawdown Investment Strategies - Newser
What data driven models say about Lexeo Therapeutics Inc.’s futureJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Volatility clustering patterns for Lexeo Therapeutics Inc.Insider Selling & AI Powered Trade Plan Recommendations - Newser
Lexeo Therapeutics Inc. stock momentum explainedQuarterly Trade Review & Free Community Supported Trade Ideas - Newser
Using fundamentals and technicals on Lexeo Therapeutics Inc.Stock Surge & Scalable Portfolio Growth Ideas - Newser
What’s next for Lexeo Therapeutics Inc. stock priceMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Is It Too Late to Sell Lexeo Therapeutics Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
How to interpret RSI for Lexeo Therapeutics Inc. stockJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
Lexeo Reports Q2 Loss as Costs Jump 129% - AOL.com
Backtesting results for Lexeo Therapeutics Inc. trading strategiesWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - Newser
Using R and stats models for Lexeo Therapeutics Inc. forecastingTake Profit & Daily Profit Focused Stock Screening - Newser
Using data tools to time your Lexeo Therapeutics Inc. exitJuly 2025 Review & Expert Approved Momentum Ideas - Newser
Lexeo Therapeutics price target lowered to $15 from $20 at Chardan - MSN
What are Lexeo Therapeutics Inc.’s recent SEC filings showingRisk Management & Long Hold Capital Preservation Plans - theviewers.co.kr
Will Lexeo Therapeutics Inc. rebound enough to break evenMarket Risk Analysis & Low Risk High Reward Trade Ideas - Newser
Quantitative breakdown of Lexeo Therapeutics Inc. recent moveQuarterly Profit Summary & Verified Entry Point Signals - Newser
Can Lexeo Therapeutics Inc. withstand a market correctionSwing Trade & Fast Gaining Stock Strategy Reports - theviewers.co.kr
Will Lexeo Therapeutics Inc. face regulatory challengesJuly 2025 Volume & Verified Chart Pattern Trade Signals - sundaytimes.kr
Momentum Shift: What are Lexeo Therapeutics Inc.’s recent SEC filings showing2025 Investor Takeaways & Growth Focused Entry Point Reports - theviewers.co.kr
Screener Results Flag Lexeo Therapeutics, Inc. as OversoldJuly 2025 Trends & Fast Gain Swing Alerts - 더경남뉴스
Aug Summary: What’s the beta of Lexeo Therapeutics Inc. stockFed Meeting & Smart Allocation Stock Tips - theviewers.co.kr
Screener Results Flag Lexeo Therapeutics Inc. as OversoldPortfolio Growth Summary & Low Drawdown Investment Ideas - newsyoung.net
Lexeo Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingEarnings Recap Summary & Short-Term Trading Opportunity Alerts - 더경남뉴스
Top Executives at Lexeo Therapeutics Make Significant Stock Sales! - TipRanks
Lexeo Therapeutics Executives Sell Shares at $4.67/Share on 2025-08-18. - AInvest
How institutional ownership impacts Lexeo Therapeutics Inc. stockJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
How to forecast Lexeo Therapeutics Inc. trends using time seriesJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
Lexeo Therapeutics’ Friedreich Ataxia Gene Therapy Receives FDA Breakthrough Therapy Designation - MSN
Lexeo Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowJuly 2025 Summary & Verified Technical Signals - Newser
Why Lexeo Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Macro Moves & Weekly Top Performers Watchlists - kangso.co.kr
Chardan Cuts Price Target on Lexeo Therapeutics to $15 From $20, Keeps Buy Rating - MarketScreener
Lexeo Therapeutics Q2 Earnings Misses, Yet Market Reacts Positively — Here’s What Investors Should Know - AInvest
Custom watchlist performance reports with Lexeo Therapeutics Inc.2025 Market Trends & Weekly High Return Stock Forecasts - Newser
Will Lexeo Therapeutics Inc. stock split in the near future2025 Support & Resistance & Free Safe Capital Growth Stock Tips - Newser
Lexeo Therapeutics Posts Q2 2025 Earnings Loss, But Backtests Suggest Strong Post-Miss Recovery - AInvest
HC Wainwright Lowers Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $9.00 - Defense World
1.33%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):